BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 27818904)

  • 1. Lanthanide-Doped Upconversion Nanoparticles: Emerging Intelligent Light-Activated Drug Delivery Systems.
    Bagheri A; Arandiyan H; Boyer C; Lim M
    Adv Sci (Weinh); 2016 Jul; 3(7):1500437. PubMed ID: 27818904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineered lanthanide-doped upconversion nanoparticles for biosensing and bioimaging application.
    Li Y; Chen C; Liu F; Liu J
    Mikrochim Acta; 2022 Feb; 189(3):109. PubMed ID: 35175435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging NIR light-responsive delivery systems based on lanthanide-doped upconverting nanoparticles.
    Le XT; Youn YS
    Arch Pharm Res; 2020 Jan; 43(1):134-152. PubMed ID: 31981073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Energy Flux Manipulation in Upconversion Nanosystems.
    Liang L; Qin X; Zheng K; Liu X
    Acc Chem Res; 2019 Jan; 52(1):228-236. PubMed ID: 30557000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combating Concentration Quenching in Upconversion Nanoparticles.
    Chen B; Wang F
    Acc Chem Res; 2020 Feb; 53(2):358-367. PubMed ID: 31633900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering of Lanthanide-Doped Upconversion Nanoparticles for Optical Encoding.
    Huang K; Idris NM; Zhang Y
    Small; 2016 Feb; 12(7):836-52. PubMed ID: 26681103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Near-Infrared Activation of Sensory Rhodopsin II Mediated by NIR-to-Blue Upconversion Nanoparticles.
    Yaguchi M; Jia X; Schlesinger R; Jiang X; Ataka K; Heberle J
    Front Mol Biosci; 2021; 8():782688. PubMed ID: 35252344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lanthanide-Doped Upconversion Nanocarriers for Drug and Gene Delivery.
    Lee G; Park YI
    Nanomaterials (Basel); 2018 Jul; 8(7):. PubMed ID: 29987223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in synthesis and surface modification of lanthanide-doped upconversion nanoparticles for biomedical applications.
    Lin M; Zhao Y; Wang S; Liu M; Duan Z; Chen Y; Li F; Xu F; Lu T
    Biotechnol Adv; 2012; 30(6):1551-61. PubMed ID: 22561011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Near-Infrared Light-Triggered Drug Release from Ultraviolet- and Redox-Responsive Polymersome Encapsulated with Core-Shell Upconversion Nanoparticles for Cancer Therapy.
    Tsai MF; Lo YL; Soorni Y; Su CH; Sivasoorian SS; Yang JY; Wang LF
    ACS Appl Bio Mater; 2021 Apr; 4(4):3264-3275. PubMed ID: 35014413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent progress of UCNPs-MoS
    Wang Y; Wang Y; Zhong H; Xiong L; Song J; Zhang X; He T; Zhou X; Li L; Zhen D
    J Mater Chem B; 2024 May; 12(21):5024-5038. PubMed ID: 38712810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled optical characteristics of lanthanide doped upconversion nanoparticles for emerging applications.
    Ge X; Liu J; Sun L
    Dalton Trans; 2017 Dec; 46(48):16729-16737. PubMed ID: 29125162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deep-penetrating photodynamic therapy with KillerRed mediated by upconversion nanoparticles.
    Liang L; Lu Y; Zhang R; Care A; Ortega TA; Deyev SM; Qian Y; Zvyagin AV
    Acta Biomater; 2017 Mar; 51():461-470. PubMed ID: 28063989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remote Light-Responsive Nanocarriers for Controlled Drug Delivery: Advances and Perspectives.
    Zhao W; Zhao Y; Wang Q; Liu T; Sun J; Zhang R
    Small; 2019 Nov; 15(45):e1903060. PubMed ID: 31599125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NIR-II Responsive Upconversion Nanoprobe with Simultaneously Enhanced Single-Band Red Luminescence and Phase/Size Control for Bioimaging and Photodynamic Therapy.
    Bi S; Deng Z; Huang J; Wen X; Zeng S
    Adv Mater; 2023 Feb; 35(7):e2207038. PubMed ID: 36398498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in functionalized upconversion nanoparticles for light-activated tumor therapy.
    Chu H; Cao T; Dai G; Liu B; Duan H; Kong C; Tian N; Hou D; Sun Z
    RSC Adv; 2021 Oct; 11(56):35472-35488. PubMed ID: 35493151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in design and fabrication of upconversion nanoparticles and their safe theranostic applications.
    Gu Z; Yan L; Tian G; Li S; Chai Z; Zhao Y
    Adv Mater; 2013 Jul; 25(28):3758-79. PubMed ID: 23813588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photo-isomerization of azobenzene containing surfactants induced by near-infrared light using upconversion nanoparticles as mediator.
    Schimka S; Klier DT; de GuereƱu AL; Bastian P; Lomadze N; Kumke MU; Santer S
    J Phys Condens Matter; 2019 Mar; 31(12):125201. PubMed ID: 30625434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applications of upconversion nanoparticles in cellular optogenetics.
    Lin Y; Yao Y; Zhang W; Fang Q; Zhang L; Zhang Y; Xu Y
    Acta Biomater; 2021 Nov; 135():1-12. PubMed ID: 34461347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymer-Functionalized Upconversion Nanoparticles for Light/Imaging-Guided Drug Delivery.
    Zhang L; Jin D; Stenzel MH
    Biomacromolecules; 2021 Aug; 22(8):3168-3201. PubMed ID: 34304566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.